- 入驻时间: 2012-04-17
- 联系人:客户经理
- 电话:400-968-7988
-
联系时,请说明易展网看到的
- Email:fuwu@bioleaf.com
产品介绍 |
|||
品名 | |||
货号 |
A254 |
||
规格 |
100 µL |
||
同种型 |
IgG1k |
||
蛋白质浓度 |
> 1.0 - 1.2 mg/mL |
||
缓冲液 |
Borate Buffered Saline |
||
物种交叉反应 |
Baboon, Cynomolgus Monkey |
||
储存 |
2°C to 8°C* (≤ 30 days) For long-term storage (> 30 days), aliquot and store at ≤ –20°C. Avoid repeated freeze-thaw |
||
使用说明 |
For Research Use Only. Not for use in diagnostic procedures |
||
产品描述 |
All of Quidel’s monoclonal antibodies to complement antigens were prepared using intact complement proteins and are purified from mouse ascites fluid via protein A affinity chromatography. The prepared monoclonal antibodies are buffer exchanged in Borate Buffered Saline containing 0.02% NaN3 |
||
背景 |
Factor H is a fluid phase complement regulatory protein consisting of a single peptide chain of 20 short consensus repeat segments or CCP’s with a molecular weight of approximately 155 KD. 1 Factor H regulates the alternative pathway of the complement system by modifying activity of the “feedback loop.” It does this in three ways. First, it is a co-factor for the serine protease Factor I, which cleaves C3b to iC3b. iC3b has no hemolytic or amplification function, but may be bound by complement receptors. Second, Factor H prevents the formation of and accelerates the disassociation of the alternative pathway C3 convertase, C3bBb from cell surfaces. Finally, Factor H binds to polyanions on host cell surfaces and tissue matrices, such as basement membranes, blocking deposition of C3b. This later activity is leveraged by many pathogens as a mode of complement evasion. 2 |
||
应用 |
Applications of this antibody have been evaluated by various research facilities, and include EIA, 5 Western Blot, 6 and FACS |
||
参考资料 |
1、Pangburn M.K. Differences between the binding sites of the complement regulatory proteins DAF, CR1 and Factor H on C3 Convertases, J Immunol 136:6, 1986. 2、Kraiczy P, Würrzner, R. Complement escape of human pathogenic bacteria by acquisition of complement regulators, Mol Immunol 43:31-44, 2006. 3、Atkinson, J.P., et al. Complement factor H and the hemolytic uremic syndrome, JEM 204:6, 1245-1248, 2007. 4、Sivaprasad, S. and Chong, N.V. The Complement system and age-related macular degeneration, Eye 1-6, 200 |